Supriya Lifescience IPO Details
IPO Date	December 16, 2021 to December 20, 2021
Listing Date	December 28, 2021
Face Value	₹2 per share
Issue Price Band	₹265 to ₹274 per share
Issue Price Final	₹274 per share
Lot Size	54 Shares
Sale Type	Fresh Capital-cum-Offer for Sale
Total Issue Size	2,55,47,445 shares
(aggregating up to ₹700.00 Cr)
Fresh Issue	72,99,270 shares
(aggregating up to ₹200.00 Cr)
Offer for Sale	1,82,48,175 shares of ₹2
(aggregating up to ₹500.00 Cr)
Issue Type	Bookbuilding IPO
Listing At	BSE, NSE
Share Holding Pre Issue	7,31,83,530 shares
Share Holding Post Issue	2,55,47,445 shares
Supriya Lifescience IPO Reservation
Supriya Lifescience IPO offers total 2,55,47,445 shares. Out of which 1,91,60,585 (75.00%) allocated to QIB, 76,64,234 (30.00%) allocated to QIB, 38,32,116 (15.00%) allocated to NII, 25,54,744 (10.00%) allocated to RII and 1,14,96,351 (45.00%) allocated to Anchor investors.

Investor Category	Shares Offered	Maximum Allottees
QIB Shares Offered	1,91,60,585 (75.00%)	NA
NII (HNI) Shares Offered	38,32,116 (15.00%)	NA
Retail Shares Offered	25,54,744 (10.00%)	47,310
Total Shares Offered	2,55,47,445 (100.00%)	
Supriya Lifescience IPO Anchor Investors Details
Supriya Lifescience IPO raises ₹315.00 crore from anchor investors. Supriya Lifescience IPO Anchor bid date is December 15, 2021. Supriya Lifescience IPO Anchor Investors list

Bid Date	December 15, 2021
Shares Offered	1,14,96,351
Anchor Portion Size (In Cr.)	315.00
Anchor lock-in period end date for 50% shares (30 Days)	January 22, 2022
Anchor lock-in period end date for remaining shares (90 Days)	March 23, 2022
Supriya Lifescience IPO Timeline (Tentative Schedule)
Supriya Lifescience IPO opens on December 16, 2021, and closes on December 20, 2021.

IPO Open Date	Thu, Dec 16, 2021
IPO Close Date	Mon, Dec 20, 2021
Tentative Allotment	Thu, Dec 23, 2021
Initiation of Refunds	Fri, Dec 24, 2021
Credit of Shares to Demat	Mon, Dec 27, 2021
Tentative Listing Date	Tue, Dec 28, 2021
Cut-off time for UPI mandate confirmation	5 PM on Mon, Dec 20, 2021
Supriya Lifescience IPO Lot Size
Investors can bid for a minimum of 54 shares and in multiples thereof.  The following table depicts the minimum and maximum investment by Individual Investors (Retail) and HNI in terms of shares and amount.

Application	Lots	Shares	Amount
Retail (Min)	1	54	₹14,796
Retail (Max)	13	702	₹1,92,348
S-HNI (Min)	14	756	₹2,07,144
S-HNI (Max)	67	3,618	₹9,91,332
B-HNI (Min)	68	3,672	₹10,06,128
Supriya Lifescience IPO Promoter Holding
Satish Waman Wagh is the company promoter.
Promoter Holding Pre Issue	99.98%
Promoter Holding Post Issue	68.24%
Note : The value will be calculated using Equity Dilution = Share Holding Pre Issue - Share Holding Post Issue

About Supriya Lifescience Ltd.
Supriya Lifescience is engaged in the manufacturing of Active pharmaceutical ingredients (APIs). As of March 31, 2021, the company produces 38 APIs focused on diverse therapeutic segments such as antihistamine, analgesic, anaesthetic, vitamin, anti-asthmatic and anti-allergic. The company has been the largest exporter of Chlorpheniramine Maleate and Ketamine Hydrochloride from India between Fiscal 2017 and 2021. The company is also one of the largest exporters of Salbutamol Sulphate from India in FY 2021 in terms of volume.

In Fiscal 2021, the company's products were exported to 86 countries to 1,296 customers including 346 distributors. The company has API business in Europe, Latin America, Asia, and North America.

Supriya Lifescience has a modern manufacturing facility in Maharashtra spread across 23,806 sq. mts, having a reactor capacity of 547 KL/ day including 7 clean rooms. The company has also acquired a plot of land, admeasuring 12,551 sq. mt, near the present manufacturing facility, to expand its manufacturing infrastructure. The company's manufacturing facility has received approvals from USFDA, EDQM TGA-Australia, KFDA-Korea, PMDA Japan, NMPA (previously known as SFDA)- China, Health Canada, in relation to API products being exported to the relevant jurisdictions by the company.

Company Financials
Summary of financial Information (Restated Standalone)
Particulars	For the year/period ended (₹ in Millions)
 	30-Sep-21	31-Mar-21	31-Mar-20	31-Mar-19
Total Assets	5,041.02	4,458.24	3,364.01	2,530.52
Total Revenue	2,300.61	3,962.21	3,227.13	2,858.62
Profit After Tax	659.59	1,238.28	733.74	394.24
Objects of the Issue (Supriya Lifescience IPO Objectives)
The Company Supriya Lifescience IPO proposes to utilise the Net Proceeds from the Issue towards the following objects:

S.No.	Objects of the Issue	Expected Amount (₹ in crores)
1	Funding capital expenditure requirements of the Company;	92.30
2	Repayment and/ or pre-payment, in full or part, of certain borrowings availed by the Company	60.00
3	General corporate purposes.	35.95
Supriya Lifescience IPO Review
[Dilip Davda]  SLL has been making strides with higher top and bottom lines year after year and exporting over 75% of products to more than 86 countries. Based on financial parameters, the issue is attractively priced leaving something on the table across the board. The issue is worth considering for short to long term rewards. Read detail review...

Supriya Lifescience IPO Subscription Status (Bidding Detail)
The Supriya Lifescience IPO is subscribed 71.51 times on December 20, 2021 7:52:00 PM (Day 4). The public issue subscribed 56.01 times in the retail category, 31.83 times in the QIB category, and 161.22 times in the NII category. Check Day by Day Subscription Details (Live Status)

Category	Subscription (times)	Shares Offered	Shares bid for
QIB	31.83	79,24,527	25,22,34,270
NII	161.22	39,62,263	63,87,80,418
Retail	56.01	26,41,509	14,79,42,450
Total	71.51	1,45,28,299	1,03,89,57,138
Supriya Lifescience IPO Prospectus
  ›  Supriya Lifescience IPO DRHP
  ›  Supriya Lifescience IPO RHP
  ›  Anchor Investors in Supriya Lifescience IPO
  ›  Supriya Lifescience IPO Final Prospectus
Supriya Lifescience IPO Listing Details
Listing Date	December 28, 2021
BSE Script Code	543434
NSE Symbol	SUPRIYA
ISIN	INE07RO01027
Final Issue Price	₹274 per share
BSE Listing Group	B (Rolling)
Pre-Open Session - NSEPre-Open Session - BSE

Listing Day Trading Information
Price Details	NSE SME	NSE SME
Final Issue Price	₹274.00	₹274.00
Open	₹425.00	₹421.00
Low	₹383.15	₹383.20
High	₹425.00	₹421.00
Last Trade	₹390.35	₹390.85